HAL (France)open access
Benefit of adding Cureety Techcare telemonitoring to usual care during injectable anticancer treatment: the OPTIMACURE multicentric French prospective randomized study
Telemonitoring, Cancer, 0, Quality of care, Chemotherapy management, Injectable anticancer treatment, Anticipated prescription
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 676788
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.